Membership hub Contact Us

Sertraline recall: Pharmacies call for compensation from manufacturers 

29th April 2026


Pharmacies, who bear the brunt of any recall, should be reimbursed for the cost of these mistakes by the manufacturers who make them.

Medicines PANA4952
Commenting on a recall of 100mg Sertraline Henry Gregg, Chief Executive of the National Pharmacy Association said:

"This has potentially serious consequences for patients and is deeply frustrating for pharmacies.

"Hard pressed pharmacy teams spend hours of their time contacting patients who have received these prescriptions as well as quarantining stock, time they could be spending delivering patient care instead.

"Pharmacies, who bear the brunt of any recall, should be reimbursed for the cost of these mistakes by the manufacturers who make them."

Share this article

Date published: 29th April 2026

National Pharmacy Association Ltd (Company No. 1281757) is registered in England and Wales and authorised and regulated by the Financial Conduct Authority. NPA Insurance Ltd (Company No. 64269) is registered in England and Wales. Authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority. Registered office: Mallinson House, 40–42 St Peters Street, St Albans, AL1 3NP. NPA Copyright © 2026. All Rights Reserved.

©2026